Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Use of OxyContin by adolescent students

Edward M. Adlaf, Angela Paglia-Boak and Bruna Brands
CMAJ April 25, 2006 174 (9) 1303; DOI: https://doi.org/10.1503/cmaj.1060037
Edward M. Adlaf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Paglia-Boak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruna Brands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Although increases in the nonmedical use of OxyContin (oxycodone) in the United States have been reported recently,1,2 few data are available to assess whether such use has diffused into general populations in Canada.

In a school survey of 7726 Ontario students in grades 7 to 12,3 1.3% of the students (95% confidence interval [CI] 0.9% to 1.7%) reported lifetime use of OxyContin, and 1.0% (95% CI 0.7% to 1.5%) reported use in the past year. Similar to the situation for other illegal drugs,3 the majority (69%) of past-year users had used the drug only once or twice. Reported use did not vary significantly by sex or grade but did vary by region, with the highest past-year use occurring among students in Northern Ontario (3.3%; 95% CI 1.8% to 6.1%).

To assess whether OxyContin users differ from the users of other illicit drugs, we compared the drug-use profiles of 105 lifetime OxyContin users and 909 users of illicit drugs other than cannabis and OxyContin. The results suggested that OxyContin is merely an addition to the repertoire of drugs used by adolescents. Among 13 illicit drugs examined (e.g., cannabis, heroin, methamphetamine, barbiturates, stimulants, tranquilizers, LSD, phencyclidine [PCP], hallucinogens, cocaine, crack, ecstasy and methylphenidate). OxyContin users were significantly more likely than nonusers to use only 4 of these drugs (heroin, barbiturates, tranquilizers and methylphenidate). This finding raises the spectre of potential polydrug reactions.

Of course, such data are not without limitations. For example, as for other illicit drugs, we would expect some degree of underreporting of OxyContin use. Also, our question was restricted to OxyContin use and thus did not yield information about the use of oxycodone in general and other opioids.

Still, these data, which constitute one of the first reports of OxyContin use within a general Canadian population, allow 2 important observations. First, at this point, there is no evidence of the diffusion of OxyContin into mainstream adolescent populations. Second, our Ontario estimates are lower than the most comparable ones available from the United States. According to US data for 2005,2 1.8% of 8th-graders, 3.2% of 10th-graders and 5.5% of 12th-graders reported past-year use of OxyContin; the corresponding data for Ontario students were 0.7% (95% CI 0.3% to 1.6%), 0.7% (95% CI 0.3% to 1.5%) and 1.4% (95% CI 0.7% to 2.7%).

REFERENCES

  1. 1.↵
    Sees KL, Di Marino ME, Ruediger NK, et al. Non-medical use of OxyContin tablets in the United States. J Pain Palliat Care Pharmocather 2005;19(2:13-23.
    OpenUrlCrossRef
  2. 2.↵
    Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the future national results on adolescent drug use: overview of key findings, 2005. Bethesda (MD): National Institute on Drug Abuse; 2006.
  3. 3.↵
    Adlaf EM, Paglia-Boak A. Drug use among Ontario students, 1977–2005: detailed OSDUS findings. Toronto: Centre for Addiction and Mental Health; 2005.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 174 (9)
CMAJ
Vol. 174, Issue 9
25 Apr 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of OxyContin by adolescent students
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of OxyContin by adolescent students
Edward M. Adlaf, Angela Paglia-Boak, Bruna Brands
CMAJ Apr 2006, 174 (9) 1303; DOI: 10.1503/cmaj.1060037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Use of OxyContin by adolescent students
Edward M. Adlaf, Angela Paglia-Boak, Bruna Brands
CMAJ Apr 2006, 174 (9) 1303; DOI: 10.1503/cmaj.1060037
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 2: special populations
  • Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 2: populations particulieres
  • Google Scholar

More in this TOC Section

  • Hospital-at-home programs in Canada: challenges and pitfalls
  • Author response to “Pitfalls of analyzing perinatal outcomes by health care provider”
  • Pitfalls of analyzing perinatal outcomes by health care provider
Show more Letters

Similar Articles

Collections

  • Topics
    • Addiction medicine
    • Adolescent medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire